Methadone maintenance treatment: Is it possible to adapt the daily doses to the metabolic activity of the patient?

被引:25
作者
Charlier, C
Dessalles, MC
Plomteux, G
机构
[1] Univ Hosp Liege, Toxicol Lab, Liege, Belgium
[2] CH Paul Guiraud Villejuif, Biol Lab, Paris, France
关键词
methadone; metabolic pathway; serum concentration; cortisol ratio;
D O I
10.1097/00007691-200102000-00001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Controversy still exists concerning the proper daily dose of methadone to be used in opiate dependency treatment. Because it is admitted that serum methadone concentration may be significantly correlated with the amount of drug available at the receptor level, it could be interesting to predict the methadone daily doses necessary to reach such a serum concentration. The authors have attempted to correlate the serum methadone level with the daily intake. considering the metabolic activity of the patients. A poor correlation was found between methadone doses and methadone serum concentrations (r(2) = 0.0409, p = 0.048). The test used to determine the metabolic activity of patients is the 6-OH cortisol/17-OH corticosteroids ratio in urine. This urinary 6-OH cortisol/17-OH corticosteroids ratio was rested because cortisol is metabolized through the same P450 cytochromes as methadone, namely cytochrome P450 3A4. This determination could be of interest because it could be tested before methadone administration to predict optimal doses. But when the authors tried to correlate the methadone serum concentration with the steroid ratio, they failed to find a significant correlation (r(2) = 0.0046, N.S.), even when they took into account the daily doses (r(2) = 0.0015, N.S.), most probably because of some limitations of the cortisol ratio.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 14 条
[1]   CORTISOL METABOLISM BY HUMAN LIVER INVITRO .1. METABOLITE IDENTIFICATION AND INTERINDIVIDUAL VARIABILITY [J].
ABEL, SM ;
MAGGS, JL ;
BACK, DJ ;
PARK, BK .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 43 (07) :713-719
[2]   CORTISOL PRODUCTION-RATE AND THE URINARY-EXCRETION OF 17-HYDROXYCORTICOSTEROIDS, FREE CORTISOL, AND 6-BETA-HYDROXYCORTISOL IN HEALTHY ELDERLY MEN AND WOMEN [J].
BARTON, RN ;
HORAN, MA ;
WEIJERS, JWM ;
SAKKEE, AN ;
ROBERTS, NA ;
VANBEZOOIJEN, CFA .
JOURNALS OF GERONTOLOGY, 1993, 48 (05) :M213-M218
[3]  
BAUER R, 1999, FUNDAM CLIN PHARM, V13, P494
[4]   METHADONE-MAINTENANCE TREATMENT - AN UPDATE [J].
BERTSCHY, G .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1995, 245 (02) :114-124
[5]   Methadone maintenance - Does dose determine differences in outcome? [J].
Blaney, T ;
Craig, RJ .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1999, 16 (03) :221-228
[6]   METHADONE DOSAGE AND RETENTION OF PATIENTS IN MAINTENANCE TREATMENT [J].
CAPLEHORN, JRM ;
BELL, J .
MEDICAL JOURNAL OF AUSTRALIA, 1991, 154 (03) :195-199
[7]  
Dessalles MC, 1996, ANN BIOL CLIN-PARIS, V54, P203
[8]   Methadone N-demethylation in human liver microsomes:: lack of stereoselectivity and involvement of CYP3A4 [J].
Foster, DJR ;
Somogyi, AA ;
Bochner, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (04) :403-412
[9]   Interaction of methadone with substrates of human hepatic cytochrome P450 3A4 [J].
Iribarne, C ;
Dreano, Y ;
Bardou, LG ;
Menez, JF ;
Berthou, F .
TOXICOLOGY, 1997, 117 (01) :13-23